tiprankstipranks
Trending News
More News >
Taysha Gene Therapies, Inc. (TSHA)
:TSHA
US Market

Taysha Gene Therapies (TSHA) Ownership - Who Owns Taysha Gene Therapies?

Compare
1,038 Followers

Taysha Gene Therapies (TSHA) Ownership Overview

13.06%9.51%30.73%6.42%40.28%
13.06% Insiders
30.73% Other Institutional Investors
6.42% ETFs
40.28% Public Companies and Individual Investors
The ownership structure of Taysha Gene Therapies (TSHA) stock is a mix of institutional, retail, and individual investors. Approximately 46.66% of the company’s stock is owned by Institutional Investors, 13.06% is owned by Insiders, and 40.28% is owned by Public Companies and Individual Investors.
The ownership structure of Taysha Gene Therapies (TSHA) stock is a mix of institutional, retail, and individual investors. Approximately 40.24% of the company’s stock is owned by Institutional Investors, 13.06% is owned by Insiders, and 6.42% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Jun 03, 2025
xxxxxxxxxxxxx
$2062500
Jul 01, 2024
xxxxxxxxxxxxx
$2999999

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Mar 31, 2025
xxxxxxxxxxxxx
$188896
Mar 31, 2025
xxxxxxxxxxxxx
$1192973

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
25,601,110Insider9.79%65,026,819
10,872,503Institution4.16%27,616,158
8,145,601Institution3.11%20,689,827
7,803,993Institution2.98%19,822,142
7,085,685Institution2.71%17,997,640
6,784,994Institution2.59%17,233,885
4,004,756Institution1.53%10,172,080
3,811,549Institution1.46%9,681,334
3,613,903Insider1.38%9,179,314
2,039,514Insider0.78%5,180,366

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
7,085,685Institution2.71%17,997,640
6,784,994Institution2.59%17,233,885
3,811,549Institution1.46%9,681,334
1,856,746Institution0.71%4,716,135
1,330,039Institution0.51%3,378,299
977,083Institution0.37%2,481,791
547,128Institution0.21%1,389,705
442,311Institution0.17%1,123,470
376,987Institution0.14%957,547
354,413Institution0.14%900,209

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
4,847,719Institution1.85%9,404,575
4,491,033Institution1.72%11,407,224
2,238,994Institution0.86%4,343,648
1,503,711Institution0.57%3,819,426
944,567Institution0.36%2,399,200
882,689Institution0.34%1,712,417
355,761Institution0.14%903,633
243,375Institution0.09%618,173
160,119Institution0.06%310,631
96,181Institution0.04%254,880

FAQ

Who Owns Taysha Gene Therapies, Inc. (TSHA)?
According to the latest TipRanks data, approximately 30.73% of the company's stock is held by institutional investors, 13.06% is held by insiders, and 40.28% is held by retail investors.
    What percentage of Taysha Gene Therapies, Inc. (TSHA) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 30.73% of Taysha Gene Therapies, Inc. (TSHA) stock is held by institutional investors.
      What percentage of Taysha Gene Therapies, Inc. (TSHA) stock is held by retail investors?
      According to the latest TipRanks data, approximately 40.28% of Taysha Gene Therapies, Inc. (TSHA) stock is held by retail investors.
        Who owns the most shares of Taysha Gene Therapies, Inc. (TSHA)?
        Paul B Manning owns the most shares of Taysha Gene Therapies, Inc. (TSHA).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis